Teladoc Health, Inc. (TDOC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 900M 1.8B 2.7B FY16: 123.2M FY17: 233.3M FY18: 417.9M FY19: 553.3M FY20: 1.1B FY21: 2B FY22: 2.4B FY23: 2.6B FY24: 2.6B FY25: 2.5B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 100M 200M 300M FY13: 15.7M FY14: 33.6M FY15: 56.3M FY16: 91.2M FY17: 171.7M FY18: 289.2M FY13 FY14 FY15 FY16 FY17 FY18

Operating Income Annual

-15B -10B -5B 0 5B 10B 15B FY16: -62.7M FY17: -75.4M FY18: -70.9M FY19: -80.4M FY20: -506.4M FY21: -265.6M FY22: -13.7B FY23: -248.6M FY24: -1B FY25: -263M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-15B -10B -5B 0 5B 10B 15B FY16: -74.2M FY17: -106.8M FY18: -97.1M FY19: -98.9M FY20: -485.1M FY21: -428.8M FY22: -13.7B FY23: -220.4M FY24: -1B FY25: -200.3M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 300M 600M 900M FY16: 32M FY17: 61.6M FY18: 128.7M FY19: 184.5M FY20: 390.8M FY21: 650.3M FY22: 744M FY23: 760M FY24: 751.3M FY25: 771.6M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-150M 0 150M 300M 450M FY16: -51.9M FY17: -34.4M FY18: -4.9M FY19: 29.9M FY20: -53.5M FY21: 194M FY22: 189.3M FY23: 350M FY24: 293.7M FY25: 294.4M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-150M 0 150M 300M 450M FY16: -54M FY17: -37.1M FY18: -8.9M FY19: 26.4M FY20: -57.5M FY21: 185.5M FY22: 172.8M FY23: 338.6M FY24: 282.9M FY25: 285.5M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 60M 120M 180M FY19: 71.8M FY20: 90.5M FY21: 156.9M FY22: 161.5M FY23: 164.6M FY24: 170.6M FY25: 176.2M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q3 '16: 9.10 Q4 '16: -1.74 Q1 '17: -1.64 Q2 '17: -1.54 Q3 '17: -1.44 Q4 '17: -1.89 Q1 '18: -1.98 Q2 '18: -2.10 Q3 '18: -1.89 Q4 '18: -1.48 Q1 '19: -1.52 Q2 '19: -1.53 Q3 '19: -1.47 Q4 '19: -1.38 Q1 '20: -1.35 Q2 '20: -1.28 Q3 '20: -1.43 Q4 '20: -5.36 Q1 '21: -6.27 Q2 '21: -6.79 Q3 '21: -6.89 Q4 '21: -2.75 Q1 '22: -43.02 Q2 '22: -61.38 Q3 '22: -61.30 Q4 '22: -84.76 Q1 '23: -43.60 Q2 '23: -24.78 Q3 '23: -24.68 Q4 '23: -1.34 Q1 '24: -1.41 Q2 '24: -5.93 Q3 '24: -5.77 Q4 '24: -5.86 Q1 '25: -5.90 Q2 '25: -1.17 Q3 '25: -1.26 Q4 '25: -1.14 Q1 '26: -0.97 Q2 '26: -0.99 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.